Home Crystal structure of 1-(4-chlorophenyl)-4-(2-furoyl)-3-phenyl-1H-pyrazol-5-ol, C20H13ClN2O3
Article Open Access

Crystal structure of 1-(4-chlorophenyl)-4-(2-furoyl)-3-phenyl-1H-pyrazol-5-ol, C20H13ClN2O3

  • Qiong Wu , Wei-Ya Zhang , Zi-Mo Zhang , Heng-Qiang Zhang ORCID logo and Tong-Yin Jin EMAIL logo
Published/Copyright: April 15, 2024

Abstract

C20H13ClN2O3, monoclinic, P21/n (no. 14), a = 6.2256(5) Å, b = 18.3976(15) Å, c = 14.5582(15) Å, β = 90.555(8)°, V = 1667.4(3) Å3, Z = 4, R gt(F) = 0.0443, wR ref(F 2) = 0.1003, T = 153(2) K.

CCDC no.: 2343323

The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal: Yellow block
Size: 0.21 × 0.17 × 0.15 mm
Wavelength: MoKα radiation (0.71073 Å)
μ: 0.25 mm−1
Diffractometer, scan mode: Multiwire proportional, ω
θ max, completeness: 29.3°, >99 %
N(hkl)measured, N(hkl)unique, R int: 14,927, 4581, 0.039
Criterion for I obs, N(hkl)gt: I obs > 2 σ(I obs), 2825
N(param) refined: 239
Programs: CrysAlis PRO [1], Shelx [2, 3], WinGX/Ortep [4], Platon [5]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

Atom x y z U iso*/U eq
C1 0.7074 (3) 0.55607 (10) 0.31733 (13) 0.0245 (4)
C2 0.6373 (3) 0.49399 (10) 0.27208 (14) 0.0287 (4)
H2 0.499873 0.476022 0.282109 0.034*
C3 0.7733 (3) 0.45901 (10) 0.21193 (14) 0.0293 (4)
H3 0.728107 0.417203 0.181469 0.035*
C4 0.9762 (3) 0.48641 (10) 0.19734 (14) 0.0278 (4)
C5 1.0458 (3) 0.54871 (10) 0.24083 (14) 0.0281 (4)
H5 1.181974 0.567159 0.229372 0.034*
C6 0.9115 (3) 0.58352 (10) 0.30158 (13) 0.0275 (4)
H6 0.957584 0.625275 0.331890 0.033*
C7 0.3986 (3) 0.57140 (10) 0.42607 (13) 0.0251 (4)
C8 0.3274 (3) 0.62890 (9) 0.47995 (13) 0.0245 (4)
C9 0.4739 (3) 0.68624 (10) 0.46027 (13) 0.0252 (4)
C10 0.4766 (3) 0.76208 (10) 0.49347 (13) 0.0242 (4)
C11 0.2930 (3) 0.80490 (10) 0.49113 (14) 0.0292 (4)
H11 0.165223 0.786174 0.467433 0.035*
C12 0.3000 (3) 0.87551 (11) 0.52407 (15) 0.0337 (5)
H12 0.177208 0.904272 0.521605 0.040*
C13 0.4881 (3) 0.90343 (11) 0.56053 (14) 0.0348 (5)
H13 0.491639 0.950621 0.583388 0.042*
C14 0.6706 (3) 0.86108 (11) 0.56290 (15) 0.0349 (5)
H14 0.797626 0.879666 0.587492 0.042*
C15 0.6651 (3) 0.79121 (10) 0.52888 (14) 0.0300 (4)
H15 0.789518 0.763249 0.529704 0.036*
C16 0.1477 (3) 0.61992 (10) 0.54161 (14) 0.0270 (4)
C17 0.1211 (3) 0.66408 (10) 0.62329 (14) 0.0310 (4)
C18 −0.0551 (4) 0.67513 (11) 0.67463 (15) 0.0373 (5)
H18 −0.191160 0.655778 0.664241 0.045*
C19 0.0068 (5) 0.72165 (13) 0.74699 (17) 0.0561 (7)
H19 −0.081097 0.739646 0.793002 0.067*
C20 0.2162 (5) 0.73494 (13) 0.73680 (17) 0.0589 (8)
H20 0.298410 0.764030 0.775793 0.071*
Cl1 1.14839 (8) 0.44089 (3) 0.12320 (4) 0.03731 (15)
H1 0.214 (4) 0.4968 (14) 0.4427 (19) 0.069 (9)*
N1 0.5723 (2) 0.59412 (8) 0.37947 (11) 0.0255 (3)
N2 0.6192 (2) 0.66617 (8) 0.39968 (11) 0.0268 (4)
O1 0.3338 (2) 0.50323 (7) 0.41839 (10) 0.0290 (3)
O2 0.0142 (2) 0.57168 (8) 0.52497 (10) 0.0397 (4)
O3 0.2934 (3) 0.69965 (8) 0.66070 (11) 0.0459 (4)

1 Source of material

All reagents were obtained from commercial sources and used without further purification. 3-Methyl-1-p-chlorophenyl-5-pyrazolone was synthesized according to the method proposed by Jensen [6] (yield 85 %; m.p. 441–443 K). 3-Methyl-1-p-chlorophenyl-5-pyrazolone (5 g) was dissolved in dioxane (100 mL) by warming and Ca(OH)2 (3 g) was added. 2-Furoyl chloride (5 mL) was next added, drop by drop, with stirring within 4 min. After refluxing gently for 1.5 h, the orange mixture was cooled and poured with stirring into chilled 2 M HCI (500 mL). A handful of ice-salt mixture was added and vigorous stirring continued for another 30 min, after which, the reaction mixture was kept in a refrigerator until crystallisation occurred. Filtration of the product gave 67 % yield of yellow crystals at room temperature.

2 Experimental details

The hydroxyl H atom was located in a difference Fourier map and refined as riding, with O–H distance restraint of 0.84(3) Å and with U iso(H) = 1.5U eq(O). Other H atoms were placed in calculated positions, with C–H = 0.93 for phenyl and furan, and refined as riding, with U iso(H) = 1.2U eq(C) for phenyl H.

3 Comment

Acylpyrazolones are an interesting class of β-diketones possessing a prominent structural motif, which is found in numerous active compounds. Due to the easy preparation and its rich biological activity in broad-spectrum of applications they are of general interest [7], [8], [9]. Alkaline-earth metal β-diketonate complexes also have recently provoked a growing interest as suitable precursors in the synthesis of high Tc superconducting films [10, 11]. So far research has been restricted to those acylpyrazolones with aryl substituents at four-positions. So far, only a few studies have involved heterocyclic substituents at the four-position. In recent years, we have reported some 4-acylpyrazolones ligands and their complexes [12], [13], [14]. Knowledge of the crystal structure of such 4-heterocyclic acylpyrazolones ligands gives us not only sufficient information about nuclearity of the complex molecule, but is important in understanding the behaviour of this compounds in the vapour phase, and the mechanisms of sublimation and decomposition.

The structure of the title compound is shown in Figure. The bond lengths and angles are within normal ranges [15]. The p-chlorophenyl ring is slightly twisted by 20.06(5)° with respect to the pyrazolone ring, whereas the furyl rings make dihedral angles of 37.87(5)° with the pyrazolone ring. Atom O1 has a partial anionic character, as shown by the lengthening of the C7=O1 bond [1.322(2) Å] relative to that normally found for carbonyl groups and this atom acts as hydrogen-bond acceptor. The intermolecular O1–H1⋯O2 hydrogen bond results in the formation of a dimer with an R2 2(12) graph-set motif [16]. It is apparent that the C16=O2 and C8=C16 distances correspond to well defined double bonds. The conjugation effects also cause the pyrazolone and C1–C6 benzene ring to be nearly coplanar, with a mean deviation from the overall plane of 0.003 Å. The clear presence of the hydroxyl H atom in the difference Fourier synthesis and the absence of any residual electronic density in the vicinity of O1 confirm that title compound crystallize as a pure hydroxyl tautomer and that no desmotropism is present [17].


Corresponding author: Tong-Yin Jin, Department of Chemistry, Hebei Normal University for Nationalities, Chengde 067000, People’s Republic of China, E-mail:

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: Science Foundation of Hebei Normal University for Nationalities (No. STZD2023001).

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. Rigaku, O. D. CrysAlisPRO; Rigaku Oxford Diffraction Ltd: Yarnton, Oxfordshire, England, 2015.Search in Google Scholar

2. Sheldrick, G. M. SHELXL2018. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Search in Google Scholar

3. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Search in Google Scholar

4. Farrugia, L. J. WinGX and ORTEP for Windows: an update. J. Appl. Crystallogr. 2012, 45, 849–854; https://doi.org/10.1107/s0021889812029111.Search in Google Scholar

5. Spek, A. L. Structure validation in chemical crystallography. Acta Crystallogr. 2009, D65, 148–155; https://doi.org/10.1107/s090744490804362x.Search in Google Scholar

6. Jensen, B. S. The synthesis of 1-phenyl-3-methyhl-4-acyl-pyrazolones-5. Acta Chem. Scand. 1959, 13, 1668–1670; https://doi.org/10.3891/acta.chem.scand.13-1668.Search in Google Scholar

7. Marchetti, F., Pettinari, C., Di Nicola, C., Tombesi, A., Pettinari, R. Coordination chemistry of pyrazolone-based ligands and applications of their metal complexes. Coord. Chem. Rev. 2019, 401, 213069; https://doi.org/10.1016/j.ccr.2019.213069.Search in Google Scholar

8. Wang, X. H., Jia, D. Z., Liang, Y. J., Yan, S. L., Ding, Y., Chen, L. M., Shi, Z., Zeng, M. S., Liu, G. F., Fu, L. W. Lgf-YL-9 induces apoptosis in human epidermoid carcinoma KB cells and multidrug resistant KBv200 cells via reactive oxygen species-independent mitochondrial pathway. Cancer Lett. 2007, 249, 256–270; https://doi.org/10.1016/j.canlet.2006.09.008.Search in Google Scholar PubMed

9. Vyas, K. M., Jadeja, R. N., Patel, D., Devkar, R. V., Gupta, V. K. A new pyrazolone based ternary Cu(II) complex: synthesis, characterization, crystal structure, DNA binding, protein binding and anti-cancer activity towards A549 human lung carcinoma cells with a minimum cytotoxicity to non-cancerous cells. Polyhedron 2013, 65, 262–274; https://doi.org/10.1016/j.poly.2013.08.051.Search in Google Scholar

10. Rahman, M., Siddiqui, A. Pyrazoline derivatives: a worthy insight into the recent advances and potential pharmacological activities. Int. J. Pharm. Pharm. Sci. 2010, 2, 165–175.10.4172/2150-3494.1000021Search in Google Scholar

11. Mukherjee, R. Coordination chemistry with pyrazole-based chelating ligands: molecular structural aspects. Coord. Chem. Rev. 2000, 203, 151–158; https://doi.org/10.1016/s0010-8545(99)00144-7.Search in Google Scholar

12. Li, J.-Z., Zhang, H.-Q., Li, H.-X., Che, P.-Z., Wang, T.-C. 1-(4-Chlorophenyl)-4-(2-furoyl)-3-(2-furyl)-1H-pyrazol-5-ol. Acta Crystallogr. 2007, E63, o1289–o1290; https://doi.org/10.1107/s1600536807006538.Search in Google Scholar

13. Xu, L.-Y., Chen, C.-C., Chen, M.-Q., Chang, Y., Sang, R.-G., Zhang, H.-Q. Crystal structure of 1-(4-chlorophenyl)-4-benzoyl-3-methyl-1H-pyrazol-5-ol, C17H13ClN2O2. Z. Kristallogr. N. Cryst. Struct. 2023, 238, 959–961; https://doi.org/10.1515/ncrs-2023-0298.Search in Google Scholar

14. Wu, Q., Huang, Z.-Y., Liu, Y.-X., Zhang, H.-Q., Jin, T.-Y., Xue, Y.-N., Liu, C. Crystal structure of 1-(p-tolylphenyl)-4-(2-furoyl)-3-methyl-1H-pyrazol-5-ol, C16H14N2O3. Z. Kristallogr. N. Cryst. Struct. 2024, 239, 327–329; https://doi.org/10.1515/ncrs-2024-0001.Search in Google Scholar

15. Allen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G., Taylor, R. Tables of bond lengths determined by X-ray and neutron diffraction. Part 1. Bond lengths in organic compounds. J. Chem. Soc. Perk. Trans. 1987, 2, S1–S19; https://doi.org/10.1039/p298700000s1.Search in Google Scholar

16. Etter, M. C., MacDonald, J. C., Bernstein, J. Graph-set analysis of hydrogen-bond patterns in organic crystals. Acta Crystallogr. 1990, B46, 256–262; https://doi.org/10.1107/s0108768189012929.Search in Google Scholar PubMed

17. Foces-Foces, C., Fontenas, C., Elguero, J., Sobrados, I. An. Quim. Int. Ed. 1997, 93, 219–224.Search in Google Scholar

Received: 2024-02-29
Accepted: 2024-03-27
Published Online: 2024-04-15
Published in Print: 2024-06-25

© 2024 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Frontmatter
  2. New Crystal Structures
  3. The crystal structure of tris((Z)-2-hydroxy-N-((E)-pyridin-2-ylmethylene)benzohydrazonato-k2O,N)europium(III), C39H30N9O6Eu
  4. Crystal structure of (E)-3-(benzylideneamino)-2-phenylthiazolidin-4-one, C16H14N2OS
  5. The crystal structure of (E)-4-fluoro-N′-(1-(o-tolyl)ethylidene)benzohydrazide, C16H15FN2O
  6. Crystal structure of (6-chloropyridin-3-yl)methyl 2-(6-methoxynaphthalen-2-yl)propanoate, C20H18ClNO3
  7. Crystal structure of methyl 3-methoxy-4-(2-methoxy-2-oxoethoxy)benzoate, C12H14O6
  8. The crystal structure of bis[(4-methoxyphenyl)(picolinoyl)amido-κ2 N:N′]copper(II), C26H22CuN4O4
  9. The crystal structure of poly[di(μ2-aqua)-diaqua-bis(3-aminopyridine-4-carboxylate-κ2 O: O′)-tetra(μ2-3-aminopyridine-4-carboxylate-κ2 O: O′)-dineodymium(III), [Nd2(C6H5N2O2)6(H2O)4] n
  10. The crystal structure of t-butyl 7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoate, C28H34FNO4
  11. Crystal structure of catena-poly[(benzylamine-κ1 N)-(sorbato-κ1 O)-(μ2-sorbato-κ2 O,O′)-copper(II), C19H23CuNO4
  12. Crystal structure of (4-(2-chlorophenyl)-1H-pyrrol-3-yl)(ferrocenyl) methanone, C21H16ClFeNO
  13. The crystal structure of N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-3-(2-methylphenyl)-2-sulfanylprop-2-enamide hydrate, C19H17BrN2O2S2
  14. The crystal structure of N′-{5-[2-(2,6-dimethylphenoxy) acetamido]-4-hydroxy-1,6-diphenylhexan-2-yl}-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide hydrate
  15. Crystal structure of 2-(naphthalen-1-yl)ethyl 2-(6-methoxynaphthalen-2-yl)propanoate, C26H24O3
  16. Crystal structure of naphthalen-1-ylmethyl 2-(6-methoxynaphthalen-2-yl)propanoate, C25H22O3
  17. Crystal structure of poly[diaqua- (μ4-5-(1H-1,2,4-triazol-1-yl)benzene-1,3-dicarboxylato-κ5N:O,O’:O’’:O’’’)calcium(II), C10H9CaN3O6
  18. Crystal structure of (E)-N′-(4-((E)-3-(dimethylamino)acryloyl)-3-hydroxyphenyl)-N, N-dimethylformimidamide, C14H19N3O2
  19. Crystal structure of (E)-3-(dimethylamino)-1-(2-hydroxy-4,6-dimethoxyphenyl)prop-2-en-1-one, C13H17NO4
  20. Crystal structure of (2-chloropyridin-3-yl)methyl-2-(6-methoxynaphthalen-2-yl)propanoate, C20H18ClNO3
  21. The crystal structure of diethyl 4-(3,4-dimethylphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate, C21H27NO4
  22. Crystal structure of (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-17-((4-(2-phenylpropyl)phenyl)ethynyl)-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one, C36H42O2
  23. Synthesis and crystal structure of 4-(4-cyclopropylnaphthalen-1-yl)-2,4-dihydro-3H-1,2,4-triazole-3-thione, C15H13N3S
  24. Crystal structure of catena-poly[aqua-(2,6-di-(2-pyridyl)-pyridine-κ3 N,N′, N″)(μ2-1,4-naphthalene dicarboxylato-κ2 O,O′)nickel(II)], C27H19NiN3O5
  25. Crystal structure of 3-(diphenylphosphoryl)-3-hydroxy-1-phenylpropan-1-one, C21H19O3P
  26. The crystal structure of R,S-{N-[(2-oxidonaphthalen-1-yl)methylidene]phenylglycinato}divinylsilicon, C23H19NO3Si
  27. The crystal structure of 1,2,4-tris(bromomethyl)benzene, C9H9Br3
  28. Crystal structure of chlorido-[4-(pyridin-2-yl)benzaldehyde-κ2 N,C]-(diethylamine-κ1 N)platinum(II), C16H18ClN2OPt
  29. Crystal structure of 3-(methoxycarbonyl)-1-(4-methoxyphenyl)-2,3,4,9- tetrahydro-1H-pyrido[3,4-b]indol-2-ium chloride hydrate, C40H48Cl2N4O9
  30. The crystal structure of 1-(2-chlorobenzyl)-3-(3-chlorophenyl)urea, C14H12Cl2N2O
  31. Hydrothermal synthesis and crystal structure of aqua-tris(4-acetamidobenzoato-κ2 O,O′)-(1,10-phenanthroline-κ2 N,N′)terbium(III) hydrate C39H36N5O11Tb
  32. The crystal structure of zwitterionic 3-aminoisonicotinic acid, C6H6N2O2
  33. The crystal structure of bis{[monoaqua-μ2-4-[(pyridine-4-carbonyl)-amino]-phthalato-κ3 N:O,O′-(2,2′-bipyridine κ2 N,N′)copper(II)]}decahydrate, C48H56N8O22Cu2
  34. Crystal structure of poly[μ10-4,4′-methylene-bis(oxy)benzoatodipotassium], C15H10K2O6
  35. The crystal structure of catena-poly[[tetraaqua[(μ2-1,4-di(4-methyl-1-imidazolyl)benzene] cobalt(II)]bis(formate)], C16H24CoN4O8
  36. The crystal structure of (E)-2-chloro-5-((2-(nitromethylene)imidazolidin-1-yl)methyl)pyridine, C10H11ClN4O2
  37. The crystal structure of (E)-1-(((2-amino-4,5-dimethylphenyl)iminio)methyl)naphthalen-2-olate, C19H18N2O
  38. Crystal structure of N-(acridin-9-yl)-2-(4-methylpiperidin-1-yl) acetamide monohydrate, C21H25N3O2
  39. The crystal structure of dichlorido-bis(3-methyl-3-imidazolium-1-ylpropionato-κ2 O,O′)-zinc(II), C14H20Cl2N4O4Zn
  40. The crystal structure of 2,8-diethyl-1,3,7,9-tetramethyl-4λ4,5λ4-spiro[dipyrrolo[1,2-c:2′,1′-f][1,3,2]diazaborinine-5,2′-naphtho[1,8-de][1,3,2]dioxaborinine], C25H29BN2O2
  41. The crystal structure of 5-tert-butyl-2-(5-tert-butyl-3-iodo-benzofuran-2-yl)-3-iodobenzofuran, C24H24I2O2
  42. Synthesis and crystal structure of methyl 2-{[4-(4-cyclopropyl-1-naphthyl)-4H-1,2,4-triazole-3-yl]thio} acetate, C18H17N3O2S
  43. The crystal structure of n-propylammonium bis(2,3-dimethylbutane-2,3-diolato)borate-boric acid (1/1), [C3H10N][C12H24BO4]·B(OH)3
  44. Crystal structure of methyl 1-(2-bromophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate, C19H17BrN2O2
  45. Crystal structure of (4-bromobenzyl)triphenylphosphonium bromide ethanol solvate, C52H48Br4OP2
  46. The crystal structure of unsymmetrical BOPHY C26H27BN4
  47. The crystal structure of Tb3B5O11(OH)2
  48. The crystal structure of (Z)-4-ethyl-2-((4-ethyl-3,5-dimethyl-1H-pyrrol-2-yl)methylene)-3,5-dimethyl-2H-pyrrol-1-ium 2,2'-spirobi[naphtho[1,8-de][1,3,2]dioxaborinin]-2-uide, C37H37BN2O4
  49. Crystal structure of bis(methylammonium) hexadecaselenidopalladate(II), (CH3NH3)2PdSe16
  50. The crystal structure of (2-diphenylphosphanylphenyl) 2-[7-(dimethylamino)-2-oxochromen-4-yl]acetate, C31H26NO4P
  51. Crystal structure of (E)-6-(4-ethylpiperazin-1-yl)-2-(3-fluorobenzylidene)-3,4-dihydronaphthalen-1(2H)-one, C23H25FN2O
  52. The structure of RUB-56, (C6H16N)8 [Si32O64(OH)8]·32 H2O, a hydrous layer silicate (2D-zeolite) that contains microporous levyne-type silicate layers
  53. Crystal structure of 4-amino-3,5-dibromobenzonitrile, C7H4Br2N2
  54. Crystal structure of 2-(naphthalen-1-yl)ethyl 2-acetoxybenzoate, C21H18O4
  55. Single-crystal structure determination of Tm3B12O19(OH)7
  56. Crystal structure determination of NdB3.6O7
  57. The crystal structure of NdB6O8(OH)5·H3BO3
  58. Crystal structure of 2-(5-ethylpyridin-2-yl)ethyl 2-(6-methoxynaphthalen-2-yl)propanoate, C23H25NO3
  59. Crystal structure of N-(1-(3,4-dimethoxyphenyl)-2-methylpropyl)aniline, C18H23NO2
  60. Crystal structure of Ba6Cd12Mn4SiF48
  61. Synthesis and crystal structure of 5-fluoro-1-methyl-2-oxo-3-(2-oxochroman-4-yl)indolin-3-yl acetate, C20H16FNO5
  62. The crystal structure of 6-methacryloylbenzo[d][1,3]dioxol-5-yl 4-nitrobenzenesulfonate, C17H13NO8S
  63. Crystal structure of ethyl 2-(3-benzyl-4-oxo-3,4-dihydrophthalazin-1-yl)- 2,2-difluoroacetate, C19H16F2N2O3
  64. The crystal structure of tetrakis(μ 2-(1H-benzimidazole-2-methoxo-κ2 N,O:O:O)-(n-butanol-κO)-chlorido)-tetranickel(II), C48H68Cl4N8O8Ni4
  65. Synthesis and crystal structure of trans-tetraaqua-bis((1-((7-hydroxy-3-(4-methoxy-3-sulfonatophenyl)-4-oxo-4H-chromen-8-yl)methyl)piperidin-1-ium-4-carbonyl)oxy-κO)zinc(II)hexahydrate, C46H64N2O28S2Zn
  66. The crystal structure of 1-(4-carboxybutyl)-3-methyl-1H-imidazol-3-ium hexafluoridophosphate, C9H15F6N2O2P
  67. Crystal structure of 1-(4-chlorophenyl)-4-(2-furoyl)-3-phenyl-1H-pyrazol-5-ol, C20H13ClN2O3
  68. Crystal structure of dimethyl (R)-2-(3-(1-phenylethyl)thioureido)-[1,1′-biphenyl]-4,4′-dicarboxylate, C25H24N2O4S
  69. The crystal structure of 1-(3-carboxypropyl)-1H-imidazole-3-oxide, C7H10N2O3
  70. Synthesis and crystal structure of dimethyl 4,4′-(propane-1,3-diylbis(oxy))dibenzoate, C19H20O6
  71. Crystal structure of methyl-1-(p-tolyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate, C20H20N2O2
  72. The crystal structure of 1-(1-adamantan-1-yl)ethyl-3-(3-methoxyphenyl)thiourea, C20H28N2OS
  73. The crystal structure of N,N′-carbonylbis(2,6-difluorobenzamide), C15H8F4N2O3
Downloaded on 21.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2024-0097/html?lang=en&srsltid=AfmBOorGj6EOm8wxnfzX8FdhlChJO_4DmASG3OPcnquBDGaw1jTvnFYt
Scroll to top button